1. Home
  2. FSCO vs LENZ Comparison

FSCO vs LENZ Comparison

Compare FSCO & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSCO
  • LENZ
  • Stock Information
  • Founded
  • FSCO 2013
  • LENZ 2019
  • Country
  • FSCO United States
  • LENZ United States
  • Employees
  • FSCO N/A
  • LENZ N/A
  • Industry
  • FSCO Trusts Except Educational Religious and Charitable
  • LENZ Medicinal Chemicals and Botanical Products
  • Sector
  • FSCO Finance
  • LENZ Health Care
  • Exchange
  • FSCO Nasdaq
  • LENZ Nasdaq
  • Market Cap
  • FSCO 1.4B
  • LENZ 1.2B
  • IPO Year
  • FSCO N/A
  • LENZ 2021
  • Fundamental
  • Price
  • FSCO $6.96
  • LENZ $46.63
  • Analyst Decision
  • FSCO
  • LENZ Strong Buy
  • Analyst Count
  • FSCO 0
  • LENZ 4
  • Target Price
  • FSCO N/A
  • LENZ $49.75
  • AVG Volume (30 Days)
  • FSCO 709.7K
  • LENZ 421.8K
  • Earning Date
  • FSCO 01-01-0001
  • LENZ 11-05-2025
  • Dividend Yield
  • FSCO 11.44%
  • LENZ N/A
  • EPS Growth
  • FSCO N/A
  • LENZ N/A
  • EPS
  • FSCO N/A
  • LENZ N/A
  • Revenue
  • FSCO N/A
  • LENZ $5,000,000.00
  • Revenue This Year
  • FSCO N/A
  • LENZ N/A
  • Revenue Next Year
  • FSCO N/A
  • LENZ $285.73
  • P/E Ratio
  • FSCO N/A
  • LENZ N/A
  • Revenue Growth
  • FSCO N/A
  • LENZ N/A
  • 52 Week Low
  • FSCO $4.08
  • LENZ $16.54
  • 52 Week High
  • FSCO $6.00
  • LENZ $50.40
  • Technical
  • Relative Strength Index (RSI)
  • FSCO 43.81
  • LENZ 62.49
  • Support Level
  • FSCO $6.58
  • LENZ $39.52
  • Resistance Level
  • FSCO $7.05
  • LENZ $50.19
  • Average True Range (ATR)
  • FSCO 0.18
  • LENZ 2.31
  • MACD
  • FSCO -0.01
  • LENZ 0.29
  • Stochastic Oscillator
  • FSCO 49.16
  • LENZ 66.54

About FSCO FS Credit Opportunities Corp.

FS Credit Opportunities Corp is a closed-end management investment company. The Fund's primary investment objective is to generate an attractive total return consisting of a high level of current income and capital appreciation, with a secondary objective of capital preservation. It predominantly invests in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments. The credit instruments in which it invests typically are rated below investment grade by rating agencies or would be rated below investment grade if rated. To achieve its investment objectives, the fund focuses on strategies such as Opportunistic Credit, Special Situations, and Capital Structure Solutions.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: